GRAMS: Multicenter, open-label study to evaluate the safety and efficacy of Gadobutrol in subjects with known or suspected renal artery disease

The PI of this project was:

This project was funded by: Bayer

The term of this project was: September 2011 to September 2013

The number of subjects scanned during this project was: 15